Clinical trial / 2017
A 7-day fasting program reduced weight, abdominal circumference, and blood pressure in patients with type 2 diabetes at 4 months.
In an explorative trial, patients with type 2 diabetes were randomized to a 7-day fasting program (Buchinger method, ~300 kcal/day liquids) followed by dietary advice, or to usual care with dietary advice only. Of 46 enrolled participants, 32 completed the 4-month trial. After 4 months, mean weight decreased by 3.5 kg in the fasting group compared to 2.0 kg in controls (p=0.03), accompanied by a greater reduction in abdominal circumference (p=0.001). Fasting also resulted in a significant decrease in systolic (p=0.01) and diastolic (p=0.003) blood pressure, as well as increased quality of life (p=0.04), while improvements in HbA1c, insulin, and HOMA-index were non-significant.
- Study type
- Randomized controlled explorative pilot trial
- Who was studied
- 46 enrolled patients with manifest type 2 diabetes mellitus treated with oral hypoglycemic agents and/or insulin (32 completed)
- What was measured
- Weight, abdominal circumference, blood pressure, quality of life, HbA1c, insulin, and HOMA-index at 4 months
THE PAPER
Effects of A One-week Fasting Therapy in Patients with Type-2 Diabetes Mellitus and Metabolic Syndrome - A Randomized Controlled Explorative Study.
Li C, Sadraie B, Steckhan N, Kessler C, Stange R, Jeitler M, Michalsen A. Exp Clin Endocrinol Diabetes, 2017.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.